# Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

> **NCT00293384** · NA · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer
- Chronic Myeloproliferative Disorders
- Gestational Trophoblastic Tumor
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Nausea and Vomiting
- Neuroblastoma
- Ovarian Cancer
- Testicular Germ Cell Tumor

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Cyclophosphamide
- **DRUG:** Dexamethasone
- **DRUG:** Granisetron hydrochloride

## Key facts

- **NCT ID:** NCT00293384
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-06
- **Final completion:** 2012-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293384, "Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00293384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*